March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Get information on what hepatitis C is, how it is spread, tests for HCV, women with HCV, and co-infection with HIV and HCV.
Last week, the 4th International Workshop on HIV & Women convened in Washington, DC. As the most well-attended meeting yet, it was a huge success.